Aug 15, 2024 | Blog, Network Spotlight
We are honored to recognize MetroHealth for their partnership with TriNetX. From increasing its clinical research opportunities to publishing more than 65 peer-reviewed manuscripts, The MetroHealth System – a nonprofit, public health system dedicated to hope, health,...
Jul 9, 2024 | Blog, Events, Published Research
Chronic Lymphocytic Leukemia (CLL), a type of slow-growing cancer of the blood and bone marrow, accounts for 25-30 percent of all leukemia in the Western world and is the most common type of leukemia in adults, with over 100,000 new global incidence cases and over...
May 13, 2024 | Blog, Network Spotlight
We are honored to recognize UKSH for their partnership with TriNetX. In the ever-evolving landscape of healthcare, collaboration isn’t just beneficial; it’s essential. TriNetX is proud to partner with our network to advance healthcare through rigorous research,...
Mar 14, 2024 | Blog, Published Research
Powered By TriNetX MIT and BIDMC’s study published by The Lancet introduces PRISM, a model for early pancreatic cancer risk, using a database of over 156 million de-identified US patients from TriNetX, LLC. PRISM accurately forecasts pancreatic cancer risk 18...